STATEMENTS OF CONSOLIDATED CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities:
Net loss	$ (8,832,499)	$ (19,890,272)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Stock-based compensation expense	363,050	820,379
Loss on investments	6,672,019	0
Amortization of intangible assets	0	126,963
Advertising expense paid with common stock	211,200	701,650
Common stock issued in connection with financing	51,010	20,003
Amortization of debt discount	1,255,368	2,293,858
Loss on the extinguishment of debt	1,452,629	0
Change in the fair value of derivatives	(3,169,156)	3,676,649
Depreciation	2,708	1,542
Impairment of goodwill and long lived assets	0	7,962,694
Changes in operating assets and liabilities
Prepaid expenses	132,039	1,782,873
HST Receivable	(1,218)	28,381
Accrued interest	97,664	54,542
Loan payable related party	0	223,016
Accrued expense related party	(199,808)	150,381
Accounts payable and accrued expense	(449,664)	1,483,767
Net cash used for operating activities	(2,414,656)	(563,573)
Cash Flows From Investing Activities:
Purchase of fixed assets	(6,263)	0
Net impact from sale of AMS building excluding mortgage payoff	539,376	0
Purchase of private company equity	(39,490)	0
Net cash provided by investing activities	493,623	0
Cash Flows From Financing Activities:
Proceeds from the sale of preferred stock	535,000	0
Proceeds from convertible loans	584,336	553,000
Repayments of convertible loans	(53,500)	(705,000)
Proceeds from notes payable	238,560	11,973
Proceeds from the sale of common stock in private placements	291,064	0
Repayment of related party loans	(255,001)	(35,400)
Net cash provided by financing activities	1,340,459	824,573
Effect of exchange rates on cash and cash equivalents	273,372	72,422
Net Increase (Decrease) In Cash	(580,574)	261,000
Cash At The Beginning Of The Period	334,969	1,547
Cash At The End Of The Period	27,767	334,969
Supplemental disclosure of cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued as a financing expense on convertible notes	51,010	130,849
Discount for beneficial conversion feature on convertible notes	508,466	1,357,978
Common stock issued related to investment in Great Northern Cannabis	0	2,478,422
Conversion of convertible notes and accrued interest into common stock	$ 1,321,974	$ 1,329,453